SCHEMBL16223017

SCHEMBL16223017

CCCCc1c(-c2ccsc2)nc(N)nc1-c1ccsc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.47
▸ ADORA1 P30542 2/20 0.47
▸ DRD2 P14416 1/20 0.42
▸ HTR6 P50406 1/20 0.42
▸ TLR8 Q9NR97 4/20 0.40
▸ TLR7 Q9NYK1 2/20 0.38
▸ CYP2A6 P11509 2/20 0.38
▸ ADK P55263 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ KDM4A O75164 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21313192 0.93 ADORA2A (0.45) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL16223135 0.93 ADORA2A (0.58) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL16223083 0.91 ADORA2A (0.43) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL12495746 0.90 ADORA2A (0.42) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL16223036 0.88 HRH2 (0.52) ADORA2AADORA1TLR8CDK5CDK5R1
SCHEMBL12495826 0.88 ADK (0.44) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL12495903 0.88 ADORA2A (0.44) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL16223070 0.87 CYP3A4 (0.50) ADORA2AADORA1TLR8TLR7CYP2A6
SCHEMBL21313155 0.86 CHRNA7 (0.43) ADORA2AADORA1DRD2HTR6TLR8
SCHEMBL16223064 0.86 ADORA2A (0.45) ADORA2AADORA1SMN1; SMN2HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US claimed
Send feedback